Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation
Author(s) -
Koji Kawamura,
Hidenori Wada,
Ryoko Yamasaki,
Yuko Ishihara,
Kana Sakamoto,
Masahiro Ashizawa,
Miki Sato,
Tomohito Machishima,
Kiriko Terasako,
Shun-ichi Kimura,
Misato Kikuchi,
Hideki Nakasone,
Rie Yamazaki,
Junya Kanda,
Shinichi Kako,
Aki Tanihara,
Junji Nishida,
Yoshinobu Kanda
Publication year - 2013
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2013.09.020
Subject(s) - medicine , hematopoietic stem cell transplantation , discontinuation , varicella zoster virus , cumulative incidence , transplantation , hazard ratio , incidence (geometry) , disease , aciclovir , immunology , pediatrics , viral disease , virus , confidence interval , herpesviridae , physics , optics
To evaluate the prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus (VZV) disease after allogeneic hematopoietic stem cell transplantation (HSCT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom